Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-086890
Filing Date
2024-10-10
Accepted
2024-10-10 16:10:23
Documents
3
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0217201-6k_universe.htm 6-K 13426
2 LETTER OF YCM CPA INC. TO THE U.S. SECURITIES AND EXCHANGE COMMISSION DATED OCTO ea021720101ex99-1_universe.htm EX-99.1 2199
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6396
  Complete submission text file 0001213900-24-086890.txt   25718
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 241365312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)